Olson Jon A

Director Olson sold 15,205 shares ($1.4M) at $91.30 avg; stock now at $87.98 after +36.3% 90-day surge.

Jon A Olson, Director of Rocket Lab, executed 10 separate sales totaling 15,205 shares for $1,388,221.21 on 2026-01-20, reducing his holdings by 4.2% to 345,630 shares. The sales occurred across a narrow price band from $89.02 to $97.92, with a blended average of $91.30, while the stock currently trades at $87.98—3.6% below the transaction prices. The timing context reveals significant volatility: the stock has surged +36.3% over the prior 90 days and +14.0% over 30 days, approaching its 52-week high of $96.30, yet the company remains unprofitable with an annual net loss of $18.3M despite strong revenue growth of 78.3%. His recent RKLB activity shows a pattern of sells executed on 2025-12-19 (generating 30-day returns of +37.2% to +57.6%) immediately followed by this 10-transaction sale just 32 days later, suggesting positioning around peak valuation rather than conviction-driven accumulation.

Director Olson sells 15,000 RKLB shares for $1.0M on 2025-12-19 at blended avg $68.18; stock now $77.55

Director Jon A Olson executed 9 separate sales totaling 15,000 shares for $1,022,772.92 on 2025-12-19, reducing his holdings from 375,835 shares to 360,835 shares (-4.0%). The sales ranged from $61.12 to $70.20 per share with a blended average of $68.18, well below the current price of $77.55. At this ticker, Olson's prior two sales on 2025-11-20 and 2024-11-19 both produced positive 30-day and 90-day returns (56.6% and 35.4% respectively), indicating poorly-timed exits relative to subsequent price appreciation. His cross-ticker track record shows a 0.00% well-timed rate on 2 prior sells with average 90-day returns of +35.4%, suggesting a consistent pattern of selling ahead of stock rallies. The company remains unprofitable with full-year net income of $-18,257,000.00 despite strong 78.3% annual revenue growth and a $41.4B market cap, creating a mismatch between valuation and profitability that may explain elevated share activity.

Director Jon A Olson sells 60,400 RKLB shares at $45.02; stock now -41.8% from 52-week high, -33.5% in 30 days.

Director Jon A Olson sold 60,400 shares (13.8% of his pre-transaction holdings) on 2025-11-20 at $45.02, reducing his position from 436,235 to 375,835 shares. The transaction occurred as RKLB has declined sharply: the stock is currently -41.8% from its 52-week high of $69.27 and down 33.5% over the trailing 30 days. Notably, in his prior RKLB sale on 2024-11-19, the stock subsequently rose 35.4% over 90 days, indicating that prior sale was poorly timed despite the recent significant selloff. The company remains unprofitable with a net loss of $18,257,000 over its most recent full fiscal year, though annual revenue growth of 78.3% shows operational expansion.

RKLB director Olson sold 50,000 shares at $20.69; stock near 52-week high, company unprofitable

Jon A Olson, a director, sold 50,000 shares (50.0K shares) of Rocket Lab USA at $20.69 on 2024-11-19, reducing his holdings from 482,275 shares to 432,275 shares. The sale occurred near the stock's 52-week high of $22.41, following a 100.8% gain over 30 days and 222.0% gain over 90 days. While Rocket Lab shows positive revenue growth at +15.9%, the company remains unprofitable with a net income of $-51,939,000.00 over its most recent full fiscal year, presenting a mixed fundamental picture. The timing of this sale near all-time highs warrants observation given the company's ongoing lack of profitability despite operational growth.